AEG vs BMNR

The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a seemingly attractive valuation with a P/E of 8.47 well below sector average and a current price below the Graham Number of $11.87, earnings volatility is extreme—recent YoY EPS growth is -3075% and Q/Q EPS growth is -1170%, signaling severe deterioration. Dividend strength is solid at 70/100 with a 5.76% yield and sustainable 44.48% payout ratio, but insider sentiment is weak at 40/100 and technical trend is deeply bearish at 10/100. Combined with erratic earnings surprises averaging -745.99% over the last four quarters, the stock appears fundamentally deteriorating despite surface-level value appeal.

BMNR exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating deteriorating financial health. While revenue growth is explosive at 627.8%, it is decoupled from profitability, as evidenced by a catastrophic operating margin of -592.09% and an astronomical Price-to-Sales ratio of 712.25. The stock has experienced a massive technical collapse from a 52-week high of $161.00 to $22.14, suggesting a speculative bubble burst. Despite a strong current ratio and zero debt, the lack of earnings and poor deterministic scores make the current valuation unsustainable.